SenesTech, Inc. (NASDAQ:SNES – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.84 and traded as low as $2.02. SenesTech shares last traded at $2.10, with a volume of 18,752 shares traded.
Wall Street Analysts Forecast Growth
SNES has been the subject of several recent analyst reports. StockNews.com began coverage on shares of SenesTech in a research note on Monday, March 17th. They set a “sell” rating for the company. HC Wainwright upped their price target on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
Get Our Latest Analysis on SNES
SenesTech Stock Down 10.5 %
SenesTech (NASDAQ:SNES – Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28. The company had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.71 million. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%. On average, equities research analysts forecast that SenesTech, Inc. will post -10.22 EPS for the current year.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MarketBeat Week in Review – 03/24 – 03/28
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Are Dividend Achievers? An Introduction
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.